Science Explorer Back to mapMap

Most cited papers from British Nuclear Medicine Society

What are the most cited papers from British Nuclear Medicine Society?

The most cited paper from British Nuclear Medicine Society is "Current practice for measurement of radionuclide therapy doses in the UK" (S. Chandler, 2004), with 83 citations. Next come "COVID-19: guidance for infection prevention and control in nuclear medicine" (34) and "Global shortage of medical isotopes threatens nuclear medicine services" (24).

Showing 50 of 88 papers. Every paper with more than 0 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Current practice for measurement of radionuclide therapy doses in the UK S. Chandler · Nuclear Medicine Communications Apr 2004 83
2 COVID-19: guidance for infection prevention and control in nuclear medicine John Buscombe, Alp Aslan Notghi, Jilly Croasdale et al. · Nuclear Medicine Communications Open access 18 Apr 2020 34
3 Global shortage of medical isotopes threatens nuclear medicine services Alan Christopher Perkins, Andrew J.W. Hilson, John Henry Hall · BMJ 5 Sep 2008 24
4 The British Decision and Subsequent Events GEOFFREY BURWELL · Spine Oct 1988 20
5 A49 Alkoxysilane groups for instant labelling of biomolecules with 18F Uzma Choudhry, Katherine E. Martin, Stefano C. G. Biagini et al. · Nuclear Medicine Communications 14 Feb 2006 14
6 Information for patients and staff concerning nuclear medicine S. E.M. Clarke, J. H. McKillop, M. C. Prescott et al. · Nuclear Medicine Communications Apr 1992 12
7 BNMS position statement on molecular radiotherapy Glenn Flux, John Buscombe · Nuclear Medicine Communications Open access 20 Jul 2021 11
8 Impact of COVID-19 on nuclear medicine in the UK Sabina Dizdarevic, Mahdi Abdulla, Taha Sewedy et al. · Nuclear Medicine Communications 18 Dec 2020 9
9 Statements of the M.R.C. isotope panel David Croft, M. N. Maisey · British Journal of Radiology 1978 7
10 Report of the 2020 British Nuclear Medicine Society survey of nuclear medicine equipment, workforce and workload Andy G. Irwin, Christine L Turner, Stewart Redman · Nuclear Medicine Communications 4 May 2022 5
11 Resolution recovery in planar bone scans Thomas Grüning, Claudia Brogsitter, Ivor W. Jones et al. · Nuclear Medicine Communications 27 Sep 2012 5
12 Reference data for 51Cr-EDTA measurements of GFR derived from live kidney donors Gurmandeep S. Grewal, S. Allen, Glen Mervyn Blake · Nuclear Medicine Communications Apr 2004 5
13 The Future of Molecular Radiotherapy Services in the UK John Buscombe · Clinical Oncology Dec 2020 4
14 UK audit of analysis of quantitative parameters from renography data generated using a physical phantom Kuldip S. Nijran, Alex S. Houston, John S. Fleming et al. · Nuclear Medicine Communications 7 Apr 2014 4
15 Preparation and analysis of 99mTc moxifloxacin as an infection specific imaging agent Roxana Kashani, Mark Stuart Cooper, Samir Das · Nuclear Medicine Communications Apr 2004 4
16 Delivery and collection of radioactive packages to and from UK hospital nuclear medicine departments Richard S Lawson, Glyn Davies, Stuart R. Hesslewood et al. · Nuclear Medicine Communications 10 Nov 2004 4
17 A comparison between upright and supine myocardial perfusion imaging with attenuation correction Deborah Tout, Christine M. Tonge, Peter A. Austin et al. · Nuclear Medicine Communications 22 Apr 2014 3
18 Checklists for quality assurance and audit in nuclear medicine Emily D. Williams, Leslie K. Harding, Jaqueline McKillop · Nuclear Medicine Communications Aug 1989 3
19 A29 THE IMPACT OF RADIOGRAPHER REPORTING ON THE CARE AND MANAGEMENT OF THE PATIENTS IN NUCLEAR MEDICINE M.E. Welsh, K. Wakefield, K. Holmes · Nuclear Medicine Communications 18 Feb 2005 3
20 P1 Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism Kashif Uddin Ahmed, Gurjinder M. K. Nijher, A. Bannerjee et al. · Nuclear Medicine Communications 14 Feb 2006 2
21 Timing of DMSA studies post-UTI Sheida Vessal, Sanjeeve Balasubramaniam, Subham Kanti Bera et al. · Nuclear Medicine Communications Apr 2004 2
22 The current cost of nuclear medicine S. E.M. Clarke, Keith G Harding, T. M. BUXTON et al. · Nuclear Medicine Communications Aug 1990 2
23 Pharmacological stress testing performed by a clinical technologist Ian T. Jones, Jakub Thornley, A. Tukan et al. · Nuclear Medicine Communications Apr 2004 2
24 CT pulmonary angiogram (CTPA) and V/Q lung scanning practice with reference to the most recent British Thoracic Society (BTS) guidelines for the management of suspected acute pulmonary embolism U. Amendy, David L. Fox, Ainsley H. Chalmers et al. · Nuclear Medicine Communications Mar 2004 2
25 Guidance from empirical risk assessment for patients receiving radioiodine therapy Tom Watson, I. A.J. Fife · Nuclear Medicine Communications Apr 2004 2
26 A1 Treadmill exercise and myocardial perfusion imaging: the relationship between target rate and ischaemia A.H. Elmegadmi, C. Randall, Neil W. Garvie · Nuclear Medicine Communications 14 Feb 2006 2
27 Whole-body and blood dosimetry for radioiodine treatment of differentiated thyroid cancer M. Haq, Brenda E. Pratt, Glenn Flux et al. · Nuclear Medicine Communications Mar 2004 2
28 The British nuclear medicine research strategy – the framework Sabina Dizdarevic, V RALPH McCREADY, Philip J. Blower et al. · Nuclear Medicine Communications 19 Feb 2024 1
29 Can administration of metoclopramide reduce artefacts related to abdominal activity in myocardial perfusion SPECT (MPS)? T. Grüning, I.W. Jones, S.M. Nevin · Nuclear Medicine Communications Mar 2004 1
30 P2 AN EVALUATION OF THE BODY SURFACE AREA CORRECTION FOR 51CR-EDTA MEASUREMENTS OF GLOMERULAR FILTRATION RATE Glen Mervyn Blake, Gurmandeep S. Grewal · Nuclear Medicine Communications 18 Feb 2005 1
31 Stakeholder perspectives on the use of positron emission tomography in phase III oncology trials in the UK Héctor Rojas-Anaya, Karoline Skogen, Kenneth Alan Miles · Nuclear Medicine Communications 27 Apr 2012 1
32 A1 SLN localization: a surgeon??s perspective Angela McKay · Nuclear Medicine Communications 19 Jun 2006 1
33 Characterizing gamma camera collimators for sentinel node detection: the effects of septal penetration Amy R. McDowell, R. Allan, D.E. Hoffland et al. · Nuclear Medicine Communications Mar 2004 1
34 Getting to grips with non-medical reporting K.L. Bunnett, Jayne Phillips · Nuclear Medicine Communications Mar 2004 1
35 37 What is the natural history of F-18 FDG uptake in arterial atheroma on PET/CT? implications for imaging vulnerable plaque Leon Menezes, Ashley M. Groves, Irfan A. Kayani et al. · Nuclear Medicine Communications 2 Feb 2007 1
36 32 Can we get better at myocardial perfusion imaging? Jade B. Lau Young, Heather Eames, J. N. Davidson · Nuclear Medicine Communications 2 Feb 2007 1
37 Audit of radiographer reporting of perfusion lung scans Mehrdad Khonsari, Tom Sulkin · Nuclear Medicine Communications Mar 2004 1
38 Serum thyroglobulin increment is a more reliable indicator of tumour recurrence in patients with thyroid carcinoma Seyed Rasoul Zakavi, Zohreh Mousavi · Nuclear Medicine Communications Apr 2004 1
39 A postal survey of quality assurance in nuclear medicine imaging in the UK during 1988 E. D. WILLIAMS, Leslie K. Harding, Jim McKillop · Nuclear Medicine Communications Mar 1989 1
40 33 Technologist led myocardial perfusion stress testing, a retrospective review of symptoms in 300 cases Julia M. Greig, Rhonda M. Williams, Gopinath Gnanasegaran · Nuclear Medicine Communications 2 Feb 2007 1
41 Comparison of tomographic radionuclide and electron beam ventriculography Ian P. Clements, Brian P. Mullan, Michael K. O’Connor · Nuclear Medicine Communications Mar 2004 1
42 A53 Solid phase synthesis of peptide radiopharmaceuticals using Fmoc-N-??-(HYNIC-Boc)-lysine, a technetium-binding amino acid M. Bashir-Uddin Surfraz, Robert Charles King, S. J. Mather et al. · Nuclear Medicine Communications 14 Feb 2006 1
43 Cardiologists and their habits: A 5 year historical analysis of referrals for myocardial imaging E Macías, S. Chilab, Neil W. Garvie · Nuclear Medicine Communications Mar 2004 1
44 Platelet production estimation in thrombocytopenic patient: a non-invasive or invasive approach? Mila V Todorović-Tirnanić, Velibor Obradović, Nada Suvajdžić et al. · Nuclear Medicine Communications Apr 2004 1
45 Finger and whole-body doses for a variety of therapy and diagnostic procedures Rosemary J Morton, Claire Greaves · Nuclear Medicine Communications Apr 2004 1
46 With an abnormal chest X-ray, is there any point in performing V/Q scintigraphy? S. Chilab, Elena Atienza Macías, Neil Garvie · Nuclear Medicine Communications Apr 2004 1
47 Radiological and radionuclide investigation of malignant otitis externa N C Okpala, Qaisar Hussain Siraj · Nuclear Medicine Communications Mar 2004 1
48 BNMS Annual Spring Meeting 13th–15th May 2024 Brent Drake · Nuclear Medicine Communications 19 Feb 2024 0
49 21 Apical thinning ??? real or artefact? N.J. Purser, H.A. Williams, C.M. Tonge et al. · Nuclear Medicine Communications 2 Feb 2007 0
50 99mTc white-cell imaging in inflammatory bowel disease: a comparison of planar vs SPECT P.G. Hillel, E.H. Lorenz, P. Metherall et al. · Nuclear Medicine Communications Apr 2004 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.